Literature DB >> 8134114

Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation.

J Marvel1, G R Perkins, A Lopez Rivas, M K Collins.   

Abstract

Murine bone-marrow derived BAF3 cells, over-expressing the human Bcl-2 gene product, showed considerably delayed onset of apoptosis when deprived of IL-3. Such Bcl-2-BAF3 cells arrested rapidly in the G1 phase of the cell cycle upon IL-3 removal, then became refractory to IL-3 re-stimulation. The delay in IL-3 induced proliferation of Bcl-2 over-expressing cells was due to down-regulation of a specific signalling pathway. In the refractory cells, IL-3 was able to stimulate protein tyrosine phosphorylation and c-myc mRNA accumulation, but not rapid Erk2 activation or cdc2 mRNA accumulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134114

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Bcl-2 activates a programme of premature senescence in human carcinoma cells.

Authors:  Elvira Crescenzi; Giuseppe Palumbo; Hugh J M Brady
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

2.  Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase.

Authors:  N N Ahmed; H L Grimes; A Bellacosa; T O Chan; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Rel/NF-kappaB represses bcl-2 transcription in pro-B lymphocytes.

Authors:  U S Sohur; M N Dixit; C L Chen; M W Byrom; L A Kerr
Journal:  Gene Expr       Date:  1999

4.  The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry.

Authors:  L A O'Reilly; D C Huang; A Strasser
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

5.  Heterogeneity of Bcl-2 expression in metastatic breast carcinoma.

Authors:  Andrea Proctor Subhawong; Hind Nassar; Marc K Halushka; Peter B Illei; Russell Vang; Pedram Argani
Journal:  Mod Pathol       Date:  2010-05-21       Impact factor: 7.842

6.  G0 function of BCL2 and BCL-xL requires BAX, BAK, and p27 phosphorylation by Mirk, revealing a novel role of BAX and BAK in quiescence regulation.

Authors:  Yelena Janumyan; Qinghua Cui; Ling Yan; Courtney G Sansam; Mayda Valentin; Elizabeth Yang
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

7.  Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats.

Authors:  R S Clark; J Chen; S C Watkins; P M Kochanek; M Chen; R A Stetler; J E Loeffert; S H Graham
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

8.  Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.

Authors:  G P Linette; Y Li; K Roth; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.

Authors:  M Weller; U Malipiero; A Aguzzi; J C Reed; A Fontana
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Reciprocal control of apoptosis and proliferation in cultured rat hepatoma arl-6 cells: roles of nutrient supply, serum, and oxidative stress.

Authors:  L Qiao; G C Farrell
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.